Ajanta Pharma Limited (NSE:AJANTPHARM)
India
· Delayed Price · Currency is INR 3,000.60
+64.20 (2.19%)
Mar 10, 2026, 11:30 AM IST
Ajanta Pharma Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 366,720 | 327,581 | 280,899 | 154,878 | 154,667 | 155,056 | Upgrade
|
| Market Cap Growth | 14.69% | 16.62% | 81.37% | 0.14% | -0.25% | 30.05% | Upgrade
|
| Enterprise Value | 359,779 | 320,489 | 276,473 | 149,016 | 149,244 | 150,485 | Upgrade
|
| Last Close Price | 2936.40 | 2593.90 | 2186.25 | 1153.99 | 1145.99 | 1129.13 | Upgrade
|
| PE Ratio | 36.16 | 35.59 | 34.42 | 26.34 | 21.70 | 23.71 | Upgrade
|
| Forward PE | 30.66 | 31.53 | 31.03 | 20.52 | 19.55 | 23.58 | Upgrade
|
| PS Ratio | 7.05 | 7.05 | 6.67 | 4.14 | 4.63 | 5.37 | Upgrade
|
| PB Ratio | 8.50 | 8.64 | 7.87 | 4.57 | 4.74 | 5.18 | Upgrade
|
| P/TBV Ratio | 8.58 | 8.75 | 7.91 | 4.58 | 4.75 | 5.20 | Upgrade
|
| P/FCF Ratio | - | 39.03 | 44.40 | 25.08 | 37.46 | 38.31 | Upgrade
|
| P/OCF Ratio | - | 28.31 | 35.78 | 19.55 | 27.54 | 26.91 | Upgrade
|
| PEG Ratio | 2.02 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | Upgrade
|
| EV/Sales Ratio | 6.92 | 6.90 | 6.57 | 3.98 | 4.47 | 5.21 | Upgrade
|
| EV/EBITDA Ratio | 25.85 | 25.59 | 23.76 | 18.74 | 16.27 | 15.22 | Upgrade
|
| EV/EBIT Ratio | 28.75 | 28.40 | 26.44 | 21.92 | 18.47 | 16.90 | Upgrade
|
| EV/FCF Ratio | - | 38.19 | 43.70 | 24.13 | 36.15 | 37.18 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.18 | 0.04 | 0.03 | 0.05 | 0.04 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | 0.06 | 0.06 | 0.06 | 0.08 | 0.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.16 | -0.15 | -0.12 | -0.24 | -0.09 | -0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.50 | -0.45 | -0.36 | -1.01 | -0.32 | -0.34 | Upgrade
|
| Net Debt / FCF Ratio | - | -0.67 | -0.67 | -1.30 | -0.71 | -0.84 | Upgrade
|
| Asset Turnover | - | 0.96 | 0.90 | 0.86 | 0.85 | 0.81 | Upgrade
|
| Inventory Turnover | - | 1.32 | 1.36 | 1.38 | 1.14 | 1.08 | Upgrade
|
| Quick Ratio | - | 1.85 | 1.98 | 1.71 | 2.15 | 1.85 | Upgrade
|
| Current Ratio | - | 2.85 | 3.05 | 2.49 | 3.50 | 3.13 | Upgrade
|
| Return on Equity (ROE) | - | 25.02% | 23.47% | 17.68% | 22.77% | 23.38% | Upgrade
|
| Return on Assets (ROA) | - | 14.61% | 14.03% | 9.73% | 12.89% | 15.68% | Upgrade
|
| Return on Invested Capital (ROIC) | 26.98% | 27.41% | 26.73% | 19.30% | 22.50% | 25.54% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 28.10% | 27.90% | 19.20% | 23.70% | 28.40% | Upgrade
|
| Earnings Yield | 2.77% | 2.81% | 2.91% | 3.80% | 4.61% | 4.22% | Upgrade
|
| FCF Yield | - | 2.56% | 2.25% | 3.99% | 2.67% | 2.61% | Upgrade
|
| Dividend Yield | 0.94% | 1.08% | 1.65% | 0.61% | 0.55% | 0.56% | Upgrade
|
| Payout Ratio | - | 37.96% | 78.68% | 15.25% | 11.54% | 12.68% | Upgrade
|
| Buyback Yield / Dilution | 0.41% | 0.66% | 1.65% | 1.19% | 0.74% | 0.21% | Upgrade
|
| Total Shareholder Return | 1.34% | 1.74% | 3.30% | 1.79% | 1.29% | 0.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.